MacroGenics
MGNX
#8690
Rank
NZ$0.46 B
Marketcap
NZ$7.23
Share price
0.24%
Change (1 day)
161.59%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.46 Billion

As of September 2026 MacroGenics has a market cap of NZ$0.46 Billion. This makes MacroGenics the world's 8690th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.46 B161.99%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Sep 19th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.46 Billion
by Nasdaq info icon info icon
NZ$0.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$275.41 B 59,680.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.796 T 389,752.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$364.24 B 78,959.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$325.16 B 70,478.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$633.03 B 137,301.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$225.03 B 48,745.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.21 B 596.96%๐Ÿ‡บ๐Ÿ‡ธ USA